FDA Commissioner Plans on Stopping Pharma from Price Gouging

On Thursday the FDA commissioner Scott Gottlieb testified before the House appropriations subcommittee on several methods that could prevent biopharma companies from gaming the system. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.